Schedule 13G ownership disclosure
Tracon Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 89237H100
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 840,022
- Percent of class
- 4.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000904454-18-000041
- Form type
- SC 13G
- Filer
- JOHNSON & JOHNSON
- CIK
- CIK 200406
- Filed
- Jan 22, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership